Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atenolol-induced pseudolymphoma.

C A Henderson1, H K Shamy

  • 1Department of Dermatology, York District Hospital, UK.

Clinical and Experimental Dermatology
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental and Edaphic Factors that Influence Spring Dead Spot Epidemics.

Phytopathology·2023
Same author

The use of haploidy to develop plants that express several recessive traits using light-seeded canola (Brassica napus) as an example.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

The association between gastro-oesophageal reflux disease and asthma: a systematic review.

Gut·2007
Same author

Suppurative panniculitis associated with alpha 1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline.

The British journal of dermatology·2001
Same author

Papuloerythroderma of Ofuji responding to treatment with cyclosporin.

Clinical and experimental dermatology·2000
Same author

Sebum excretion rates in mothers and neonates.

The British journal of dermatology·2000

Pseudolymphoma syndrome is a reversible condition causing fever, swollen lymph nodes, and rash. This case highlights atenolol as a potential drug trigger, expanding the list of implicated medications beyond anticonvulsants.

Area of Science:

  • Pharmacology
  • Immunology
  • Dermatology

Background:

  • Pseudolymphoma syndrome is a rare, reversible condition characterized by fever, lymphadenopathy, and rash.
  • Historically, anticonvulsant medications have been the primary drugs implicated in pseudolymphoma syndrome.
  • The spectrum of causative agents is expanding, necessitating broader clinical awareness.

Observation:

  • This report details a specific case of pseudolymphoma syndrome.
  • The patient presented with symptoms consistent with the syndrome.
  • The condition was found to be associated with the use of atenolol.

Findings:

  • Atenolol, a beta-blocker, is identified as a potential causative agent in pseudolymphoma syndrome.
  • This finding expands the known iatrogenic causes of pseudolymphoma syndrome.

Related Experiment Videos

  • The syndrome's reversibility upon drug withdrawal is a key characteristic.

    • Implications:

    • Clinicians should consider atenolol and other non-anticonvulsant drugs when diagnosing pseudolymphoma syndrome.
    • Early recognition and drug withdrawal are crucial for managing this reversible condition.
    • Further research may elucidate the precise immunological mechanisms underlying drug-induced pseudolymphoma.